<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>MDM4, a homolog of MDM2, is considered a key negative regulator of p53 </plain></SENT>
<SENT sid="1" pm="."><plain>Gene amplification of MDM4 has been identified in a variety of <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> </plain></SENT>
<SENT sid="2" pm="."><plain>MDM2 or MDM4 gene amplification is only associated with the <z:mp ids='MP_0002169'>wild-type</z:mp> TP53 gene in <z:hpo ids='HP_0009919'>retinoblastomas</z:hpo>, thus the amplification of the two genes is mutually exclusive </plain></SENT>
<SENT sid="3" pm="."><plain>Previously, we demonstrated that MDM2 amplification and TP53 alteration were not mutually exclusive in <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e>, and we identified a subset of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> patients without alterations in either the TP53 or the MDM2 gene </plain></SENT>
<SENT sid="4" pm="."><plain>In this study, we investigated the gene amplification status of MDM4 in the same set of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cases </plain></SENT>
<SENT sid="5" pm="."><plain>Unexpectedly, MDM4 amplification was rare, detected in only 1.4% (3 out of 211) of <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> cases </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> the three gene-amplified <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> also harbored TP53-inactivating mutations </plain></SENT>
<SENT sid="7" pm="."><plain>This contradicts the simple mutually exclusive relationship observed in <z:hpo ids='HP_0009919'>retinoblastomas</z:hpo> </plain></SENT>
<SENT sid="8" pm="."><plain>Surprisingly, two of the three MDM4-amplified <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumors</z:e> also demonstrated MDM2 amplification </plain></SENT>
<SENT sid="9" pm="."><plain>Paradoxically, the MDM4 protein levels were decreased in the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> tissue of the gene-amplified cases compared with levels in the matched <z:mpath ids='MPATH_458'>normal</z:mpath> mucosa </plain></SENT>
<SENT sid="10" pm="."><plain>We speculate that MDM4 might play a role in colorectal <z:e sem="disease" ids="C0596263" disease_type="Neoplastic Process" abbrv="">carcinogenesis</z:e> that is not limited to negative regulation of p53 in combination with MDM2 </plain></SENT>
<SENT sid="11" pm="."><plain>The functional significance of MDM4 is still unclear and further studies are needed </plain></SENT>
</text></document>